What is EGFR?
Epidermal growth factor receptor (EGFR) is a protein found on the surface of cells. It helps cells grow and divide. It is usually the primary target in targeted therapies.
How does EGFR mutation cause lung cancer?
Some non-small cell lung cancer (NSCLC) cells have too many EGFR proteins, which cause them to grow faster. Mutations in the EGFR are present in 10 percent to about 25 percent of NSCLC tumors.
High quality EGFR mutations screening with a simple blood draw
Pangenia EGFR Mutation Plasma Screening detects EGFR gene mutations in circulating cell free tumor DNA (cfDNA) found in NSCLC patients.
Instead of taking sample directly from the tumor site, Pangenia EGFR mutation plasma screening can capture DNA shed by tumors or cancer cells in the blood. This noninvasive procedure completely simplifies the sample taking process. Pangenia EGFR mutation plasma screening can eliminate the discomfort caused to patients and valuable time used for waiting. This is exceptionally beneficial for patients who have difficulties performing bronchoscopy or other form of biopsies.
Who should consider this test?
Diagnosed/ Suspected lung cancer patients. Pangenia EGFR mutation plasma screening also facilitates the sampling of patients who are not able to sample by bronchoscopy or other form of biopsy, e.g. elderlies.
What should I do if my test results are positive?
Please consult your physicians for professional advices.